Fig. 6From: In silico drug repositioning based on the integration of chemical, genomic and pharmacological spacesThe guilt-by-association principle behind our in silico drug repositioning. If a drug with unknown indication profile shares a similar property with another drug whose indication profile is known, the former may share the same indication profile with the latterBack to article page